Squarepoint’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$798K Sell
2,446
-3,822
-61% -$1.25M ﹤0.01% 1652
2025
Q1
$1.69M Sell
6,268
-121,429
-95% -$32.8M ﹤0.01% 1248
2024
Q4
$30M Buy
127,697
+84,996
+199% +$20M 0.03% 259
2024
Q3
$11.7M Sell
42,701
-56,093
-57% -$15.4M 0.02% 452
2024
Q2
$24M Sell
98,794
-481,647
-83% -$117M 0.04% 254
2024
Q1
$86.7M Buy
580,441
+244,615
+73% +$36.6M 0.15% 50
2023
Q4
$64.3M Buy
335,826
+98,192
+41% +$18.8M 0.12% 91
2023
Q3
$42.1M Buy
237,634
+70,011
+42% +$12.4M 0.1% 122
2023
Q2
$31.8M Buy
167,623
+34,395
+26% +$6.53M 0.1% 131
2023
Q1
$26.7M Buy
133,228
+131,019
+5,931% +$26.2M 0.11% 134
2022
Q4
$525K Sell
2,209
-35,541
-94% -$8.45M ﹤0.01% 1435
2022
Q3
$7.56M Sell
37,750
-87,350
-70% -$17.5M 0.04% 348
2022
Q2
$18.2M Buy
125,100
+87,662
+234% +$12.8M 0.1% 150
2022
Q1
$6.11M Buy
+37,438
New +$6.11M 0.03% 431
2021
Q3
Hold
0
2202
2021
Q2
Hold
0
2583
2021
Q1
Sell
-23,308
Closed -$3.03M 2515
2020
Q4
$3.03M Sell
23,308
-4,183
-15% -$544K 0.02% 580
2020
Q3
$4M Buy
27,491
+24,359
+778% +$3.55M 0.05% 395
2020
Q2
$464K Sell
3,132
-8,604
-73% -$1.27M 0.01% 1341
2020
Q1
$1.28M Sell
11,736
-66,557
-85% -$7.24M 0.03% 616
2019
Q4
$9.02M Buy
+78,293
New +$9.02M 0.05% 324
2019
Q3
Sell
-21,792
Closed -$1.58M 2205
2019
Q2
$1.58M Buy
21,792
+9,472
+77% +$687K 0.02% 968
2019
Q1
$1.15M Buy
+12,320
New +$1.15M 0.01% 1026
2018
Q4
Sell
-74,930
Closed -$6.56M 1893
2018
Q3
$6.56M Sell
74,930
-15,188
-17% -$1.33M 0.08% 324
2018
Q2
$8.88M Buy
90,118
+61,372
+213% +$6.04M 0.12% 260
2018
Q1
$3.42M Buy
+28,746
New +$3.42M 0.05% 406
2017
Q3
Sell
-26,530
Closed -$2.12M 1576
2017
Q2
$2.12M Buy
26,530
+15,730
+146% +$1.25M 0.04% 499
2017
Q1
$554K Sell
10,800
-700
-6% -$35.9K 0.02% 811
2016
Q4
$431K Buy
11,500
+4,500
+64% +$169K 0.02% 922
2016
Q3
$474K Buy
+7,000
New +$474K 0.03% 583
2016
Q2
Sell
-8,000
Closed -$502K 1080
2016
Q1
$502K Buy
8,000
+2,800
+54% +$176K 0.04% 627
2015
Q4
$490K Buy
+5,200
New +$490K 0.05% 549